Saturday, June 3, 2023 | Back issues
Courthouse News Service Courthouse News Service

Diabetic Supplements

A putative class action against GNC over labeling on diabetic supplements may continue, a federal court in California ruled. Consumers claim labels describing the product’s functions did not include a disclaimer required under the Federal Food, Drug and Cosmetics Act.

SAN FRANCISCO – A putative class action against GNC over labeling on diabetic supplements may continue, a federal court in California ruled. Consumers claim labels describing the product’s functions did not include a disclaimer required under the Federal Food, Drug and Cosmetics Act.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...